Effects of NVP-BEZ235, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, on HTLV-1-infected T-cell lines.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Oncology Letters

• Publication date

  2018-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3892/ol.2018.7979PMID 29552172PMCID PMC5840529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomarkers and Preclinical Models for Adult T-Cell Leukemia-Lymphoma Treatment

  2019cited by this paper
• The combination of NVP-BEZ235 and rapamycin regulates nasopharyngeal carcinoma cell viability and apoptosis via the PI3K/AKT/mTOR pathway

  2018cited by this paper
• Targeting the translation machinery in cancer

  2015cited by this paper
• Clinical efficacy of mTOR inhibitors in solid tumors: a systematic review.

  2015cited by this paper
• Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers

  2014cited by this paper
• Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma

  2014cited by this paper
• Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors

  2014cited by this paper
• The PI3 kinase inhibitor NVP-BKM120 induces GSK3/FBXW7-dependent Mcl-1 degradation, contributing to induction of apoptosis and enhancement of TRAIL-induced apoptosis.

  2013cited by this paper
• The phosphatidylinositol-3-kinase inhibitor NVP-BKM120 overcomes resistance signals derived from microenvironment by regulating the Akt/FoxO3a/Bim axis in chronic lymphocytic leukemia cells

  2013cited by this paper
• Development of PI3K inhibitors: lessons learned from early clinical trials

  2013cited by this paper
• Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas.

  2013cited by this paper
• Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study.

  2012cited by this paper
• Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment

  2012cited by this paper
• Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone

  2011cited by this paper
• Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas.

  2010cited by this paper
• Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.

  2010cited by this paper
• The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma

  2010cited by this paper
• Targeting the phosphoinositide 3-kinase pathway in cancer

  2009cited by this paper
• Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity

  2008cited by this paper
• International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

  2008cited by this paper
• Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.

  2007cited by this paper
• mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt.

  2006cited by this paper
• Serum level of soluble CD30 correlates with the aggressiveness of adult T‐cell leukemia/lymphoma

  2005cited by this paper
• The Retinoblastoma Protein and Cell Cycle Control Review

  2004cited by this paper
• Determination of subcutaneous tumor size in athymic (nude) mice

  2004cited by this paper
• A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability.

  1997cited by this paper
• A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells.

  1996cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Significance of soluble interleukin‐2 receptor levels for evaluation of the progression of adult T‐cell leukemia

  1994cited by this paper
• The retinoblastoma protein and the cell cycle.

  1992cited by this paper
• Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease.

  1984cited by this paper

• The role of SIK3 in HER2+ gastric cancer cells

  2024cites this paper
• PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities

  2023cites this paper
• Mechanisms Involved in the Promoting Activity of Fibroblasts in HTLV-1-Mediated Lymphomagenesis: Insights into the Plasticity of Lymphomatous Cells

  2021cites this paper
• Pharmacologic inhibition of Akt in combination with chemotherapeutic agents effectively induces apoptosis in ovarian and endometrial cancer cell lines

  2020cites this paper
• Harmine and Piperlongumine Revert TRIB2-Mediated Drug Resistance

  2020cites this paper
• Apoptosis as a mechanism for the treatment of adult T cell leukemia: promising drugs from benchside to bedside.

  2020cites this paper
• The role of CUDC‐907, a dual phosphoinositide‐3 kinase and histone deacetylase inhibitor, in inhibiting proliferation of adult T‐cell leukemia

  2020cites this paper
• Biomarkers and Preclinical Models for Adult T-Cell Leukemia-Lymphoma Treatment

  2019cites this paper
• The combination of NVP-BEZ235 and rapamycin regulates nasopharyngeal carcinoma cell viability and apoptosis via the PI3K/AKT/mTOR pathway

  2018cites this paper